

MUMBAI:
Since earlier this week, a large number of Bollywood Celebrities namely Alia Bhatt, Rajkummar Rao, Ajay Devgan, Kartik Aaryan, Anil Kapoor, Shraddha Kapoor, Sara Ali Khan, Arjun Kapoor amongst significant others have come forward to support Hyderabad based family in their journey of saving their child Ayaansh Gupta.
Actor Rajkummar Rao Instagram Post read, “Ayaansh needs world’s most expensive drug. You are his last hope! Link in Bio to donate. Please donate as he doesn’t have too many days left for this injection. I’ve done my bit, it’s your turn now.”
2-year-old Ayaansh is diagnosed with Spinal Muscular Atrophy (SMA) Type 1, his parents Rupal and Yogesh Gupta have taken to crowdfunding on ImpactGuru.com to cover the cost of Zolgensma therapy.
SMA is a rare genetic disease that attacks the baby’s nerves and muscles, and as it progresses, makes it extremely difficult for the child to carry out basic activities like sit up, lift their head, swallow milk, and even breathe. SMA is currently the leading genetic cause of infant death worldwide, and it affects 1 in 10,000 babies.
Currently, Ayaansh is of 2 years and 10 months of age and has a chest deformation called pigeon’s chest. The child requires physiotherapy daily for at least 4-5 hours. Baby Ayaansh is on a complete liquid diet as he is unable to swallow properly. On an average day, he vomits around 5 times. He needs BiPAP support for breathing for 12 hours a day and often suffers from sleep apnea. Even when he has a cough, the little boy needs a tube i.e. catheter to remove the phlegm.
The only ray of hope for Baby Ayaansh is Zolgensma, a one-time gene replacement therapy. Commercially Zolgensma is available in the USA for approximately USD $2.1 million (INR 16 crores). But the world’s most expensive medicine is not possible to arrange for a middle-class couple like the Guptas.
This is the ideal time for little Ayaansh to take the medicine as it is only approved for children who have a bodyweight of fewer than 13.5 kilograms. Ayaansh’s weight is 10 kilograms.
In a heartfelt appeal, Ayaansh’s parents said, “Please donate on our ImpactGuru fundraiser to relieve little Ayaansh of the daily torture of his condition. Every small amount will be one step closer to the required amount. Even sharing this story on social media platforms will be of immense help.”
In 70 days, Baby Ayaansh’s ImpactGuru fundraiser has raised over Rs. 5.60 crore cumulatively contributed from 25,000+ donors.
One of the updates on Ayaansh’s ImpactGuru fundraiser read, “Thank you, for your amazing response to our SOS call. Without your constant inspiration and love, we would have probably crumbled under the pressure of arranging Ayaansh’s life-altering crores. But we stand strong because we have you by our side. Do keep sharing Ayaansh’s story to make it go viral. We need all your help to save our sweet boy and on time. Help us.”
more recommended stories
Aalekh Foundation Announces 3rd Edition of the Aalekh Women Achievers AwardsNEW DELHI:Anshu Arora, one of the.
Bihar Police Bans Makeup for Women Officers on DutyPATNA:The Bihar Police Headquarters has issued.
India Gears up for First-Ever Digital Census In 2027 with Caste Data, Self-Enumeration FeaturesNEW DELHI:India is set to conduct.
Four of Family from Hyderabad Charred to Death in US AccidentHYDERABAD:Four members of a family from.
Arms-drug Smuggling Racket Busted in Amritsar, 9 Held with Heroin & WeaponsAMRITSAR:In a major breakthrough under the.
Sub Lt Astha Poonia Becomes Indian Navy’s First Woman Fighter PilotNEW DELHI:In a landmark achievement that.
India’s Operation Sindoor Exposes Pakistan’s Defence Gaps, says PM Sharif’s AideNEW DELHI:In a stunning revelation that.
SC to Examine Plea of Former SIMI Head Seeking Clarification on Sedition AppealNEW DELHI:The Supreme Court on Thursday.
Another Batch of 5,246 Yatris Leave for Valley as Amarnath Yatra BeginsJAMMU:Another batch of Yatris left Jammu.
B’luru Stampede: ‘No Magical Powers with Police’, CAT Recommends Reinstatement of 5 CopsBENGALURU:The Central Administrative Tribunal (CAT), while.